Skip to content

Evaluation of Surgical Treatment of Terrible Triade Injury of the Elbow Joint

Evaluation of Surgical Treatment of Terrible Triade Injury of the Elbow Joint

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04578977
Enrollment
20
Registered
2020-10-08
Start date
2020-10-10
Completion date
2022-12-31
Last updated
2020-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment of Terrible Triade Injury of the Elbow Joint

Brief summary

) Terrible triad injury of the elbow is a complex injury that is classically defined as elbow dislocation along with fractures of the coronoid process of the ulna and the radial head. The injury is usually associated with typical soft-tissue disruptions (with common involvement of the lateral collateral ligament complex, elbow joint capsule, as well as the common extensor and flexor-pronator tendons)(2). Complications of terrible triad injuries include redislocation, residual instability, elbow stiffness, heterotopic ossification, fracture malunion or nonunion, elbow arthrosis, olecranon bursitis, ulnar or radial nerve palsy (due to the surgical approach or placement of hardware), and hardware related complications(2) . Management of trrible triade is conservative or surgical treatment ,in this study we will use surgical treatment and make evaluation of it.

Detailed description

The elbow is the second most commonly dislocated joint in adults and up to 20% of dislocations are associated with a fracture. (1) Terrible triad injury of the elbow is a complex injury that is classically defined as elbow dislocation along with fractures of the coronoid process of the ulna and the radial head. The injury is usually associated with typical soft-tissue disruptions (with common involvement of the lateral collateral ligament complex, elbow joint capsule, as well as the common extensor and flexor-pronator tendons) Complications of terrible triad injuries include redislocation, residual instability, elbow stiffness, heterotopic ossification, fracture malunion or nonunion, elbow arthrosis, olecranon bursitis, ulnar or radial nerve palsy (due to the surgical approach or placement of hardware), and hardware related complications. Management of trrible triade is conservative or surgical treatment ,in this study we will use surgical treatment and make evaluation of it. Surgical treatment involves radial head repair or replacement ,medial and lateral collateral ligament repair and coronoid fracture fixation. aim of research isFunctional assessment of surgical treatment of terrible triade injury of the elbow according to Mayo elbow performance score, According to the system of Mayo, scores of 90-100 are classified as excellent, 75-89 as good, 60-74 as fair, and 0-59 as poor

Interventions

BEHAVIORALFunctional assessment of surgical treatment of terrible triade injury of the elbow

Functional assessment of surgical treatment of terrible triade injury of the elbow

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
17 Years to No maximum

Inclusion criteria

* 1.skeletally mature patients (over 17 years old) including both sexes. 2.Acute fractures within 3 weeks of injury. 3.Isolated & closed fractures . 4.polytrauma trauma patients with no other injuries in the same limb.

Exclusion criteria

* 1\. pathological fracture of proximal radius and ulna. 2. deteriorateed general health. 3. previous history of dysfunction with the affected elbow.

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of Surgical Treatment of Terrible Triade Injury of the Elbow joint.2 yearsFunctional assessment of surgical treatment of terrible triade injury of the elbow according to Mayo elbow performance score

Countries

Egypt

Contacts

Primary ContactAbdalraouf Mahmoud Ghozaly, resident doctor
Abdalraoofmahmoud4@gmail.com01555167657
Backup ContactHosam Abdalmenem Abu beih, professor
hossamabubeih@gmail.com01002228963

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026